[1] Thomas J, Ren J. Obstructive sleep apnoea aid cardiovascular complications: perception versus knowle[J]. Clinical Exp Pharmacol Physiology,2012,39 (12):995- 1003. [2] 邝良鉴,陈飞鹏.睡眠呼吸暂停低通气综合征与代谢综合征的关系[J].广东医学,2011,32(10):1352-1355. [3] 彭文压慧娣.阻塞性睡眠呼吸暂停综合征的研究进展[J].中国医药导刊2013,l5(9):1458-1459. [4] 汪成. 2型糖尿病患者血清FGF21与阻塞性睡眠呼吸暂停综合征的相关性研究[D].昆明医科大学,昆明,2014. [5] 中华医学会呼吸病学分会睡眠呼吸学组,中华医学会糖尿病学分会.阻塞性睡眠呼吸暂停与糖尿病专家共识[J].中华糖尿病杂志,2010,2:1-7. [6] 林其昌,黄建钗,丁海波,等.福州市20岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J].中华结核和呼吸杂志,2009,32:193-197. [7] Aronsohn RS, Whitmore H, Van Cauter E, et al. The association between obstructive sleep apnea syndrome and microvascula rcomplications in well-controlled diabetic patients[J]. Am J RespirCrit Care Med,2010,181:507-513. [8] Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes[J]. Diabetes Care,2009,32:1017-1019 [9] Lam DC, Lui MM, Lam JC, et al. Prevalence and recognition of obstructive sleep apnea in Chinese patients with type 2 diabetes mellitus[J]. Chest,2010,138: 1101- 10 1107. [10] 刘然,陆菊明,刘剑峰,等.2型糖尿病患者阻塞性睡眠呼吸暂停综合症患病情况及相关因素分析[J].中华老年心血管病杂志,2013,15(1):29~31. [11] Kashine S, Kishida K,Funahashi T, et al. Characteristics of sleep-disordered breathing in Japanese patients with type 2 diabetes mellitus[J]. Metabolism, 2010, 12 59:690-696. [12] 刘然.2型糖尿病合并阻塞性睡眠呼吸暂停综合症患病情况、临床特点及相关因素分析[D].解放军医学院,北京,2013 [13] Guest JF,Panca M,Sladkevicius E,Taheri S, Stradling J. Clinical Outcomes and
2015, Vol. 22 
